Pharmacists and medication reconciliation: a review of recent literature
Authors Patel E, Pevnick JM, Kennelty KA
Received 16 November 2018
Accepted for publication 28 February 2019
Published 30 April 2019 Volume 2019:8 Pages 39—45
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Professor Jonathan Ling
Eesha Patel,1 Joshua M Pevnick,2,3 Korey A Kennelty1
1Department of Pharmacy and Practice, Division of Health Services Research, University of Iowa, Iowa City, IA, USA; 2Department of Medicine, Division of General Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA; 3Department of Biomedical Sciences, Division of Informatics, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Background: Adverse drug event (ADE) errors are common and costly in health care systems across the world. Medication reconciliation is a means to decrease these medication-related injuries and increase quality of care. Research has shown that medication reconciliation accuracy and efficiency improved when pharmacists are directly involved in the process.
Objective: We review studies examining how pharmacists impact the medication reconciliation process and we discuss pharmacists’ future roles during the medication reconciliation process and then barriers pharmacy staff may face during this critical process.
Methods: A comprehensive literature search from MEDLINE and manual searching of bibliographies was performed for the time period January 2012 through November 2018.
Conclusion: Although the issue of rising costs and injury due to medication errors in our health care system are not solvable via medication reconciliation alone, it is the first and perhaps most critical piece of the medication management puzzle. As such, numerous organizations have called for pharmacists to expand their roles in the medication reconciliation process due to their expertise in medication management.
Keywords: medication reconciliation, pharmacists, adverse drug events
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]